INCYTE CORPORATION (INCY) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Win.
66/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 9 wins, 3 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinINCY / S&P 20.44% / 15.20% |
LoseINCY / S&P INCY unavailable / 15.00% |
LoseINCY / S&P INCY unavailable / 50.40% |
| 2026-Q12/3 |
LoseINCY / S&P -4.71% / -4.33% |
WinINCY / S&P 21.48% / 11.30% |
WinINCY / S&P 2732.00% / 27.70% |
| 2025-Q43/3 |
WinINCY / S&P 16.46% / 2.65% |
WinINCY / S&P 21.22% / 9.00% |
WinINCY / S&P 3105.00% / 13.40% |
| 2025-Q33/3 |
WinINCY / S&P 24.54% / 8.12% |
WinINCY / S&P 18.09% / 4.61% |
WinINCY / S&P 4114.29% / 13.45% |
| 2025-Q23/3 |
WinINCY / S&P 12.47% / 10.94% |
WinINCY / S&P 18.87% / 4.83% |
WinINCY / S&P 1102.78% / 10.63% |
| 2025-Q11/3 |
LoseINCY / S&P -12.34% / -4.27% |
WinINCY / S&P 17.13% / 4.98% |
LoseINCY / S&P -92.42% / 10.57% |
| 2024-Q42/3 |
WinINCY / S&P 4.49% / 2.41% |
WinINCY / S&P 14.76% / 5.25% |
LoseINCY / S&P -92.45% / 6.15% |
| 2024-Q32/3 |
WinINCY / S&P 9.04% / 5.89% |
WinINCY / S&P 12.94% / 5.89% |
LoseINCY / S&P -92.55% / 6.11% |
| 2024-Q22/3 |
WinINCY / S&P 6.41% / 4.28% |
WinINCY / S&P 9.78% / 5.38% |
LoseINCY / S&P -77.78% / 5.12% |
| 2024-Q12/3 |
LoseINCY / S&P -9.27% / 10.56% |
WinINCY / S&P 8.58% / 5.71% |
WinINCY / S&P 129.17% / 5.59% |
| 2023-Q42/3 |
LoseINCY / S&P 8.69% / 11.69% |
WinINCY / S&P 8.87% / 6.81% |
WinINCY / S&P 75.50% / 7.78% |
| 2023-Q31/3 |
LoseINCY / S&P -7.20% / -3.27% |
WinINCY / S&P 8.35% / 7.52% |
LoseINCY / S&P -52.16% / -5.03% |
| 2023-Q20/3 |
LoseINCY / S&P -13.86% / 8.74% |
LoseINCY / S&P 5.81% / 9.50% |
LoseINCY / S&P -61.88% / -8.57% |
| 2023-Q11/3 |
LoseINCY / S&P -10.02% / 7.50% |
WinINCY / S&P 11.41% / 10.77% |
LoseINCY / S&P -65.71% / -15.69% |
| 2022-Q42/3 |
WinINCY / S&P 20.53% / 7.56% |
WinINCY / S&P 13.67% / 11.88% |
LoseINCY / S&P -64.64% / -17.99% |
| 2022-Q32/3 |
LoseINCY / S&P -12.28% / -4.88% |
WinINCY / S&P 14.35% / 13.47% |
WinINCY / S&P 62.40% / -1.41% |
| 2022-Q23/3 |
WinINCY / S&P -4.34% / -16.10% |
WinINCY / S&P 22.05% / 13.71% |
WinINCY / S&P 177.78% / 11.04% |
| 2022-Q12/3 |
WinINCY / S&P 8.20% / -4.60% |
LoseINCY / S&P 15.24% / 15.97% |
WinINCY / S&P 92.66% / 42.23% |
| 2021-Q40/3 |
LoseINCY / S&P 6.72% / 11.03% |
LoseINCY / S&P 11.98% / 15.00% |
LoseINCY / S&P -407.19% / 96.40% |
| 2021-Q31/3 |
LoseINCY / S&P -18.25% / 0.58% |
WinINCY / S&P 18.58% / 10.77% |
LoseINCY / S&P -253.16% / 69.42% |
| 2021-Q21/3 |
LoseINCY / S&P 3.52% / 8.55% |
WinINCY / S&P 13.95% / 6.58% |
LoseINCY / S&P -266.30% / 51.81% |
| 2021-Q11/3 |
LoseINCY / S&P -6.56% / 6.17% |
WinINCY / S&P 21.24% / -1.06% |
LoseINCY / S&P -223.86% / 7.39% |
| 2020-Q41/3 |
LoseINCY / S&P -3.08% / 12.15% |
WinINCY / S&P 23.53% / -3.72% |
LoseINCY / S&P -168.14% / -33.42% |
| 2020-Q31/3 |
LoseINCY / S&P -13.69% / 8.93% |
WinINCY / S&P 16.55% / -2.04% |
LoseINCY / S&P -184.95% / -27.10% |
| 2020-Q22/3 |
WinINCY / S&P 41.98% / 20.54% |
WinINCY / S&P 19.03% / -0.46% |
LoseINCY / S&P -165.25% / -27.11% |
| 2020-Q12/3 |
WinINCY / S&P -16.14% / -19.60% |
WinINCY / S&P 11.61% / 3.47% |
LoseINCY / S&P -250.43% / -14.75% |
| 2019-Q43/3 |
WinINCY / S&P 17.63% / 9.07% |
WinINCY / S&P 14.71% / 5.36% |
WinINCY / S&P 300.00% / 2.99% |
| 2019-Q31/3 |
LoseINCY / S&P -12.63% / 1.70% |
WinINCY / S&P 17.25% / 5.02% |
LoseINCY / S&P -450.94% / 0.21% |
| 2019-Q21/3 |
LoseINCY / S&P -1.22% / 4.30% |
WinINCY / S&P 15.98% / 6.64% |
LoseINCY / S&P -382.00% / 8.65% |
| 2019-Q12/3 |
WinINCY / S&P 35.26% / 13.65% |
WinINCY / S&P 30.18% / 8.12% |
LoseINCY / S&P -246.25% / 14.29% |
| 2018-Q42/3 |
WinINCY / S&P -7.95% / -13.52% |
WinINCY / S&P 22.50% / 9.05% |
LoseINCY / S&P -132.48% / 18.23% |
| 2018-Q31/3 |
LoseINCY / S&P 3.10% / 7.71% |
WinINCY / S&P 26.72% / 10.21% |
LoseINCY / S&P -33.75% / 19.06% |
| 2018-Q21/3 |
LoseINCY / S&P -19.60% / 3.43% |
WinINCY / S&P 32.38% / 9.03% |
LoseINCY / S&P -35.90% / 14.46% |
| 2018-Q12/3 |
LoseINCY / S&P -12.02% / -0.76% |
WinINCY / S&P 25.12% / 7.68% |
WinINCY / S&P 48.15% / 12.46% |
| 2017-Q41/3 |
LoseINCY / S&P -18.87% / 6.64% |
WinINCY / S&P 38.93% / 7.03% |
LoseINCY / S&P -390.74% / 13.82% |
| 2017-Q31/3 |
LoseINCY / S&P -7.28% / 4.48% |
WinINCY / S&P 38.65% / 5.68% |
LoseINCY / S&P -201.27% / 17.57% |
| 2017-Q21/3 |
LoseINCY / S&P -5.81% / 3.09% |
WinINCY / S&P 38.80% / 4.83% |
LoseINCY / S&P -305.26% / 17.74% |
| 2017-Q12/3 |
WinINCY / S&P 33.31% / 6.07% |
WinINCY / S&P 42.94% / 3.67% |
LoseINCY / S&P -316.00% / 13.32% |
| 2016-Q43/3 |
WinINCY / S&P 6.34% / 3.82% |
WinINCY / S&P 46.70% / 2.09% |
WinINCY / S&P 2600.00% / 7.05% |
| 2016-Q32/3 |
WinINCY / S&P 17.89% / 3.85% |
WinINCY / S&P 61.41% / 0.20% |
LoseINCY / S&P -258.00% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | INCY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 50.98% | 20.78% |
| Annualized return | 50.98% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | INCY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 65.83% | 83.14% |
| Annualized return | 10.65% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | INCY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 58.07% | 319.30% |
| Annualized return | 4.69% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |